Research output

Repetitive transcranial magnetic stimulation treatment for depressive disorders: current knowledge and future directions

Research output: Contribution to journalArticleAcademicpeer-review

Associated researcher

  • Chris, B.
  • Brem, A.
  • Arns, M.
  • Brunoni, A. R.
  • Filipčić, I.
  • Ana, G.
  • Langguth, B.
  • Padberg, F.
  • Poulet, E.
  • Rachid, F.
  • Sack, Alexander T.

  • Vanderhasselt, M.
  • Bennabi, D.

Associated organisations


PURPOSE OF REVIEW: After three decades of clinical research on repetitive transcranial magnetic stimulation (rTMS), major depressive disorder (MDD) has proven to be the primary field of application. MDD poses a major challenge for health systems worldwide, emphasizing the need for improving clinical efficacy of existing rTMS applications and promoting the development of novel evidence-based rTMS treatment approaches.

RECENT FINDINGS: Several promising new avenues have been proposed: novel stimulation patterns, targets, and coils; combinatory treatments and maintenance; and personalization and stratification of rTMS parameters, and treatment of subpopulations.

SUMMARY: This opinion review summarizes current knowledge in the field and addresses the future direction of rTMS treatment in MDD, facilitating the establishment of this clinical intervention method as a standard treatment option and continuing to improve response and remission rates, and take the necessary steps to personalize rTMS-based treatment approaches.

View graph of relations


Original languageEnglish
JournalCurrent Opinion in Psychiatry
Publication statusE-pub ahead of print - 27 May 2019